Autologous stem cell transplantation, also known as autologous hematopoietic stem cell transplantation, may have a certain impact on fertility after the procedure, but the specifics need to be analyzed in conjunction with gender, the use of medication, and so on.
Autologous hematopoietic stem cell transplantation, which means collecting the patient’s own hematopoietic stem cells and then transplanting them to the patient to achieve therapeutic effects, is a means of treating myelodysplastic syndromes, leukemia, and other malignant blood diseases.
The therapy itself is not harmful to the body, except that it requires the use of oversized doses of radiotherapy and chemotherapy drugs (such as Marfan) during the period, which may cause damage to the ovaries, testes and other genitals, affecting the patient’s fertility.
Relatively speaking, the impact on women is greater than men, and the higher the dose of drugs used, the more obvious the impact on fertility.
Whether or not fertility is possible after autologous hematopoietic stem cell transplantation, just follow the doctor’s instructions for treatment.